TribLIVE

| Home


 
Larger text Larger text Smaller text Smaller text | Order Photo Reprints

AGH heart specialists to join clinical trial

Daily Photo Galleries

Wednesday, March 14, 2012
 

Heart specialists at Allegheny General Hospital announced today that they will join a clinical trial investigating an implantable device designed to provide patients with coronary artery disease an early warning of an impending heart attack.

AGH is the only Pittsburgh area hospital testing the new device — the AngelMed Guardian System.

"Patient outcomes following heart attack are largely dependent upon how quickly the cardiac injury is diagnosed and therapeutic efforts are initiated to restore blood flow to the heart. Delays in that process can result in permanent damage to heart muscle," said Dr. David Lasorda, director of the hospital's division of Interventional cardiology and its principal investigator in the study.

The American Heart Association estimates that one of every five deaths in the United States is attributable to coronary heart disease. Furthermore, 50 percent of heart-attack fatalities occur within one hour of symptom onset and often before the patient even reaches the hospital.

Subscribe today! Click here for our subscription offers.

 

 
 


Show commenting policy

Most-Read Stories

  1. Crosby banned from Jets game because he missed All-Star Game
  2. Former Steelers LB Haggans to do time in Westmoreland jail
  3. LeBeau won’t join Cardinals coaching staff
  4. Emergency room visits decline as navigators steer patients to proper medical care
  5. Business roundup: IBM “flatly denies” report of mass layoffs; more
  6. Armstrong spared worst of nor’easter’s wrath
  7. Teen found in Riverview Park last year died of overdose
  8. MSA Safety products in demand to protect workers in dangerous jobs
  9. Ford City officials discuss code enforcement
  10. Penn Hills superintendent resigns
  11. Pittsburgh cracks down on overcrowded houses